Thomas R Carper disclosed buy in Revance Therapeutics, Inc. - Common Stock
Thomas R Carper disclosed buy activity in Revance Therapeutics, Inc. - Common Stock.
Signal
Congress Trade
Action
Buy
Capital
$1,001 - $15,000
Why it matters
Congress disclosures can highlight policy-adjacent trading activity. This card is generated from canonical action facts, not request-time scraping.